• Endoscopy Ultrasound Market is Driven by the Rise in Adoption of Endoscopy Ultrasound Techniques - Endoscopy ultrasound (EUS) combines the advantages of endoscopic access and ultrasound imaging, enabling health care providers to more accurately diagnose and treat the conditions of the gastrointestinal tract. The global endoscopy ultrasound market was valued at approximately US$ 600.0 Mn in 2017 and is anticipated to expand at a CAGR of over 5.0% during the forecast period to reach a value of approximately US$ 1,000 Mn in 2026. Rise in adoption of endoscopy ultrasound techniques owing to their higher accuracy in diagnosis and treatment of gastrointestinal (GI) diseases is expected to drive the market from 2018 to 2026. Read Report Overview: https://www.transparencymarketresearch.com/endoscopy-ultrasound-market.html Major applications of endoscopy ultrasound (EUS) in the diagnosis of gastrointestinal cancers, including pancreatic, liver, and other cancers and increase in prevalence of gastrointestinal cancers are driving demand for endoscopy ultrasound products such as endoscopes, probes, and EUS needles, globally. According to statistics from the American Cancer Society (ACS), pancreatic cancer is among the leading causes of deaths globally. An estimated 53,070 people in the U.S. were diagnosed with pancreatic cancer in 2016, and an estimated 41,000 deaths were related to pancreatic cancer in 2016. According to GLOBOCAN, there were an estimated 782,000 new cases of liver cancer globally in 2013. Rise in incidence of GI cancers, new and innovative product offerings by market players, and opening of new application areas for EUS techniques were some of the major factors propelling the market in 2017. Moreover, market players are focusing on constant innovations in their product offerings. Endoscopy ultrasound techniques are being utilized in areas apart from oncology, and demand for new endoscopy ultrasound techniques such as elastography and contrast-enhanced endoscopy ultrasound (CE-EUS) is on the rise. This is fuelling demand for new and advanced products in the global market. These factors are further projected to boost the market from 2018 to 2026. The Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and other agencies have laid down strict policies for the training and education of skilled professionals performing endoscopy ultrasound techniques. However, lack of skilled professionals in the sector and lack of training and education programs in emerging countries are projected to be major restraining factors of the global endoscopy ultrasound market in the coming years. The global endoscopy ultrasound market can be segmented based on product, application, procedure, technology, end-user, and region. Based on product, the global endoscopy ultrasound market can be classified into endoscopes, ultrasound probes, ultrasonic processors, imaging systems, needles, and accessories. Innovative product offerings in the endoscopes segment and increase in application of endoscopy ultrasound techniques are likely to propel the segment in the near future. In terms of application, the global market can be categorized into oncology (upper GI oncology and lower GI oncology), pancreatic conditions, and others. Based on technology, the global endoscopy ultrasound market can be divided into radial scanning technology and linear scanning technology. In terms of procedure, the global market can be classified into upper EUS, lower EUS, EUS-guided fine-needle aspiration, and others. Based on end-user, the global endoscopy ultrasound market can be categorized into hospitals, ambulatory surgery centers, specialty clinics, and diagnostic centers. In terms of region, North America accounted for a dominant share of the global endoscopy ultrasound market in 2017. Higher demand for advanced diagnostic techniques in oncology, availability of new and advanced products in the U.S., and increase in incidence of gastric cancers were some of the major factors leading to the increased adoption of endoscopy ultrasound techniques in the market in North America 2017. The adoption of EUS techniques is steadily gaining pace in Asia Pacific, owing to the implementation of proper training and educational programs for surgeons and rise in preference of health care providers for minimally invasive EUS techniques in the diagnosis and treatment of gastrointestinal conditions. This is projected to drive the comparatively higher growth of the endoscopy ultrasound market in Asia Pacific from 2018 to 2026. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26810 Key companies operating in the global endoscopy ultrasound market and profiled in the report include Olympus Corporation, PENTAX Medical, FUJIFILM Corporation, Medtronic, CONMED Corporation, and Boston Scientific Corporation. These players are adopting organic and inorganic growth strategies to expand their product offerings, strengthen their geographical reach, and consolidate their market share in the global endoscopy ultrasound market. For instance, in September 2017, PENTAX Medical and Hitachi Medical Systems Europe announced the launch of a new ultrasound video bronchoscope (EBUS), EB19-J10U, in combination with Hitachi’s innovative ultrasound systems. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Jan 29 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Respiratory Inhaler Devices Market Analysis, Trends -

  Future Market Insights (FMI) delivers key insights on the global respiratory inhaler devices market in its upcoming outlook titled, “Respiratory Inhaler Devices Market: Global Industry Analysis and Opportunity Assessment, 2015 – 2025”. In terms of value, the global respiratory inhaler devices market is projected to register a healthy CAGR of 4.3% during the forecast period due to various factors. This FMI report offers vital and detailed insights regarding these factors.

  The respiratory inhaler devices market is segmented on the basis of product type, disease indications, technology and region. Based on the product segmentation, the overall market has been categorised into metered dose inhaler (MDI), dry powder inhaler (DPI) and nebuliser.

  Nebulisers are further sub-segmented into ultrasonic nebuliser, mesh nebuliser and compressed air nebuliser. The metered dose inhaler segment is estimated to account for maximum share in the global respiratory inhaler devices market by 2015 end, and expected to register a CAGR of 4.5% in terms of value during the forecast period 2015-2025. Currently, metered dose inhaler is a major contributor to market growth in Europe, North America and parts of Asia Pacific. Demand for nebulisers is expected to expand at a CAGR of 3.8% through 2025.

  Increase in prevalence of asthma, COPD and other respiratory disorders, especially among paediatric and the geriatric population, is a major factor driving growth of the global respiratory inhaler devices market. Other driving factors include strategic alliances among key players in the market, manufacturers focusing on enhancing market share, and expansion of the healthcare sector in developing countries due to growing investments by major players. Further, surge in demand for respiratory inhaler devices in all acute and moderate asthma and COPD conditions owing to increasing health awareness and growing disposable income is projected to result in increased spending on respiratory inhaler devices. This in turn is expected to bolster respiratory inhaler devices market growth during the forecast period.

  Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-493

   Lack of effective drugs for certain respiratory disorders, concerns about side-effects and complications, lack of skilled pulmonologists and healthcare professionals, lack of awareness among patients, and high prices of inhaler devices are the key factors hampering growth of this market.

  Currently, combined therapies offer more associated benefits, such as reliablility, increased efficacy, and favourable reimbursement policies. Owing to these factors, patients with complex respiratory disorders are more inclined towards adopting such therapies.

  However, the cost associated with combination therapies is higher as compared to conventional therapies for patients with complex respiratory disorders. The global respiratory inhaler devices market is expected to be driven by the increased usage of newly introduced triple combination therapy for COPD patients in the coming years.

  This report assesses trends driving each segment and offers analysis and insights about the potential of respiratory inhaler devices market in specific regions. North America is estimated to dominate the respiratory inhaler devices market with maximum market share by end of 2015. North America and Western Europe are collectively expected to account for over 64.1% of the total respiratory inhaler devices market share in terms of value by end of 2015. Asia Pacific excluding Japan is estimated to witness highest CAGR of 5.0% over the forecast period, followed by North America, due to increasing prevalence of asthma and COPD among children and the geriatric population.

  Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-493

  Some key companies covered in this report include AstraZeneca, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Cipla Ltd.,  Koninklijke Philips N.V.,  PARI Medical Holding ,Teva Pharmaceutical Industries Ltd., Beximco Pharmaceuticals Ltd., OMRON Healthcare Europe B.V. and Merck & Co., Inc.

  (Added: Tue Jan 29 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Multiplex Assays Market: Rising Prevalence of Infectious Diseases and Cancer to Bolster the Growth - Multiplex assays can be defined as the type of immunoassay that employs magnetic beads for simultaneously measuring a range of analytes in a single reaction. Multiplex assays are considered to be derivatives of enzyme linked immunosorbent assay (ELISA). However, these are preferred over singleplex ELISA, owing to their advantages such as high throughput, greater output per sample volume, and increased efficiency. Read Report Overview: https://www.transparencymarketresearch.com/multiplex-assays-market.html The global multiplex assays market is anticipated to reach US$ 4,277.31 Mn by 2026, expanding at a CAGR of 7.90% from 2018 to 2026. Expansion of the market can be attributed to the advantages offered by multiplex assays over singleplex assays, rising prevalence of infectious diseases and cancer that can be detected easily at earlier stages, government and private funding for carrying out research, and strategic acquisitions among market players to enhance the reach of the multiplex assay kits. However, the high cost of instruments used to perform multiplex assays, non-availability of diagnostic kits, and lack of skilled labor are anticipated to restrain the market. In terms of product, the market has been segmented into instruments, consumables, and software. The consumables segment has been further sub-segmented into reagents and kits, microplates and micropipettes, and others. Consumables was the dominant segment in 2017. It is anticipated to remain dominant during the forecast period. It is anticipated to propel at a high CAGR during the forecast period, owing to the significant increase in focus on research and development by major market players, which would lead to repeat orders for consumables, contributing to the rise in revenues. Among the consumables segment, the reagents and kits sub-segment is expected to account for a major share of the consumables segment, in terms of revenue, during the forecast period. Based on technology, the market has been classified into multiplex RT-PCR, flow cytometry, fluorescence, luminescence, and others. The flow cytometry segment dominated the market in 2017. It is anticipated to remain dominant during the forecast period. Robust expansion of the segment can be attributed to the ease of performing multiplex assays through this technology, which offers the flexibility of running a large number of samples simultaneously with accuracy. This, in turn, fuels the segment. Additionally, the focus on development of multiplex bead-based assays for flow cytometers propels the segment. In terms of type, the market has been segregated into protein, nucleic acid, and cell. The protein segment has been further sub-segmented into planar and bead-based. The nucleic acid segment has been split into planar and bead-based. The protein segment dominated the market in 2017. It is expected to expand at a significant CAGR during the forecast period. Expansion of the segment can be attributed to the increase in analyzing protein samples precisely and simultaneously for dynamic and static as well as predictive, descriptive, and biological research. In terms of protein segment, the bead-based sub-segment is anticipated to remain dominant during the forecast period, owing to its application in the analysis of various infectious diseases and autoimmune diseases. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=49884 Based on application, the market has been divided into research & development, diagnosis, and others. The research & development segment has been further segmented into drug discovery & development and biomarker research & application. The diagnosis segment has been further sub-split into infectious diseases, autoimmune diseases, cancer, cardiovascular diseases, neuro-endocrine diseases, and others. The research & development segment is expected to expand at a notable CAGR during the forecast period, due to rise in focus of market players on investments in their research on multiplex assays. Moreover, increasing availability of multiplex kits approved only for research purposes and government and non-government funding for research aid in the growth of the segment. In terms of end-user, the market has been bifurcated into academic and research centers, biotechnology and biopharmaceutical companies, diagnostic centers, hospitals, and others. The biotechnology and biopharmaceutical companies segment dominated the market in 2017. It is expected to remain lucrative during the forecast period. Expansion of the segment can be attributed to the increase in focus on the establishment of biotechnology companies in emerging economies. Furthermore, increase in the number of biotechnology companies, globally, particularly in Europe and Asia, is expected to boost the segment. In terms of region, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe, cumulatively, accounted for over 68% of the market. They and are anticipated to remain dominant in terms of revenue during the forecast period. North America is anticipated to remain dominant during the forecast period owing to the presence of leading market players in the region, aiding in the easy and rapid availability of instruments and reagents for conducting assays and the strategic mergers and partnerships among players. The market in Asia Pacific is anticipated to expand at a significant pace during the forecast period. Expansion of the market in the region is expected to be contributed by India and Japan, due to the rise in the geriatric population leading to the increase in prevalence of infectious diseases owing to the weakening immune system. Key companies operating in the global multiplex assays market include Luminex Corporation, Thermo Fisher Scientific, Inc., Seegene, Inc., Meso Scale Diagnostics, LLC., Abcam plc, Bio-Rad Laboratories, Inc., QIAGEN N.V., Merck KGaA, Quansys Biosciences, and Illumina, Inc. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=49884 About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Jan 29 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Diagnostic Specialty Antibodies Market Value to Reach US$ 35,000 Mn by 2026 - Antibody is a blood protein produced in response to a specific antigen. An antibody is also known as immunoglobulin and is generally Y-shaped in structure. Advances in genetic engineering have made antibodies, especially monoclonal antibodies, more robust and efficacious as these increase the binding capacity to any type of specific antigen and are quite effective as a diagnostics tool to evaluate various infectious diseases. However, demand for diagnostic specialty antibodies is anticipated to decline during the forecast period owing to failure of antibodies in rapid diagnostic test for routine diagnosis and high cost of monoclonal antibodies. Read Report Overview: https://www.transparencymarketresearch.com/diagnostic-specialty-antibodies-market.html The global diagnostic specialty antibodies market was valued at US$ 20,000 Mn in 2017 and is projected to expand at a CAGR of 5% from 2018 to 2026 to reach US$ 35,000 Mn by 2026. Surge in government investment in diagnostic health care and increase in launch of new, innovative biologic diagnostic kits are likely to fuel the growth of the global diagnostic specialty antibodies market from 2018 to 2026. High unmet needs in the global diagnostic specialty antibodies market present lucrative opportunities for existing players and new entrants. For instance, Abcam plc plans to strengthen its position in Asia, specifically in China, to increase market share in unpenetrated segments and offer custom products and licensing. Additionally, in November 2016, Roche launched the global cancer immunotherapy Centers of Research Excellence (imCORE) network which brings together world’s leading scientific and clinical experts in cancer immunotherapy to collaborate in investigating promising new treatment approaches. The company announced investment up to CHF 100 Mn (US$ 98 Mn) to support basic and clinical research collaborations related to cancer immunotherapy. In terms of antibody type, the global diagnostic specialty antibodies market has been segmented into monoclonal antibodies, polyclonal antibodies, and recombinant polyclonal antibodies. The monoclonal antibodies segment is projected to account for the largest market share by 2026. However, the polyclonal antibodies segment is anticipated to expand at the highest CAGR during the forecast period. Based on application, the market has been classified into hepatitis diagnosis, tuberculosis diagnostics, dengue diagnostics, oncology diagnostics, HIV diagnostics, infectious disease diagnostics, and others. The oncology diagnostics segment is expected to expand at a high CAGR from 2018 to 2026. The infectious disease diagnostics segment held major market share in 2017. The tuberculosis diagnostics segment is likely to grow at a sluggish pace during the forecast period. In terms of end-user, the global diagnostic specialty antibodies market has been categorized into hospitals, diagnostic laboratories, and others. In terms of revenue, North America dominated the global diagnostic specialty antibodies market in 2017, owing to increase in demand for specialty antibody diagnostics for HIV, hepatitis delta virus (HDV) infections, and other infectious disease diagnosis and rise in adoption of various antibody kits in hospitals and private clinics. Europe held a significant market share in 2017, owing to the availability of technologically advanced research and development platforms for the diagnosis of disorders, increase in incidence of infectious diseases, large patient pool for HIV diagnosis, and launch of innovative and advanced kits by major manufacturers. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=54984 Leading players operating in the global diagnostic specialty antibodies market are F. Hoffmann-La Roche Ltd, Sanofi, and Abbott Laboratories. These players offer products with proprietary technologies. Others include Abcam plc, Bio-Rad Laboratories, Inc., Boehringer Ingelheim International GmbH, Agilent Technologies, Inc., and Aytu BioScience, Inc. Aytu Bioscience, Inc. invests in research and developmental activities to develop new and innovative products. It recently acquired and anticipates to commercialize FDA-approved ProstaScint (capromab pendetide), a radiolabeled monoclonal antibody. In January 2016, the company acquired a high-performance analytical flow cytometer platform from Propel Labs. This enables advanced and novice users to perform basic and multi-parameter cytometry for a wide range of applications and chemistries. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Jan 29 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Single-use Bioprocessing Systems Market to Reach Value of US$ 7,259.9 Mn in 2026 - The global single-use bioprocessing systems market has registered substantial growth in the last few years. Currently, an evident shift has been observed in the adoption pattern of small and medium-sized biotechnology & biopharmaceutical startups toward accepting single-use technologies and products. With rapid growth of the biotechnology and biopharmaceutical industries, manufacturers are now actively looking toward developing innovative treatment solutions which will give them not only a competitive edge over market rivals, but also help reduce the development time of new products with greater efficacy. Additionally, single-use bioprocessing systems help manufacturers and suppliers perform pilot studies at lower capital costs. Reputation of single-use technologies has been growing rapidly in research and development, precisely in drug development, although it is slowly moving from a dormant to a nascent growth stage in cGMP production of biologics. Read Report Overview: https://www.transparencymarketresearch.com/single-use-bio-processing-systems-market.html The global single-use bioprocessing systems market has been segmented based on product, application, end-use, and region. Based on product and application, bags and monoclonal antibodies segments are estimated to dominate the market during the forecast period. Proliferation in research and development activities in the pharmaceutical & biotechnology industry and rise in mergers & acquisitions which helps in adoption of new techniques in development of products are expected to drive the growth of the segments in the near future. Single-use bioreactors comprise a disposable bag instead of a typical culture vessel made from stainless steel or glass. Over the past two decades, single-use bioreactors have been in use in the biopharmaceutical industry and have made significant improvement in technology and ergonomics, due to their co-development with the users of the system. Also, advancements in sensor technology and automation have led vendors to incorporate intuitive and user-friendly controls in the apparatus. Customized products are co-developed with inputs from end-users, and since users can best describe challenges faced during usage, vendors have been able to deliver products with the best possible solution to overcome such challenges through incorporation of cutting-edge technologies in the development of the product. Increasing demand for single-use bioprocessing bags in various end-user industries across the globe is driving the market. However, apprehension over purity of the product remains a concern due to possibility of extractables and leachables from the plastic component of the bag interacting with culture components during fermentation. Vendors are thus highly focused on quality assurance of the products and in procuring of resins and plastic films. Premier companies in the global single-use bioprocessing systems market, such as, Thermo Fisher Scientific and GE Healthcare sell their bags after subjecting them to a host of tests for material and sterility-based safety. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3753 Major end-users in the global single-use bioprocessing systems market include pharmaceutical organizations and contract research organization (CRO) & contract manufacturing organization (CMO). In recent times, manufacturing efficiency has gained precedence in biopharmaceutical organizations and contract manufacturing organizations. In a bid to optimize profits as well as gain a competitive edge by getting products faster to the market, pharmaceutical companies are embracing single-use technologies, especially for their newly opened biologics facilities. They manufacture multiple products, and thus the adoption of single-use technologies helps them manage time and cost effectively. CROs and CMOs are projected to register high growth rate during the forecast period from 2018 to 2026. This can be attributed to the low capital investment needed to install single-use bioprocessing systems at their facilities as well as the rising trend of outsourcing in the biopharmaceutical industry. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Jan 29 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Hire Dental Fit Out Experts to Create Your Dream Practice - Setting up a dental practice may be challenging and time-consuming, for one must observe all the applicable standards in terms of dental care, hygiene and safety. Dental practices are bound to provide high-quality care to their patients; in other words, they must be safe, effective and responsive to people’s needs. In case you have decided to start your own practice, the first thing you should do is choose the location of your cabinet and have it equipped with the necessary dental equipment. In case you want to be sure that nothing is omitted, you should resort to a dental fit out provider. The costs associated with starting your own business as a dentist may be pretty high; if you want to keep your expenses under control, seeking the help of dental practice refurbishment specialists may be the best option for you. They will put at your disposal premium dental equipment, including dental chairs, dental compressors, delivery systems, dental vacuums and any other piece of equipment that you may require. With their help, you will be able to save significant amounts of money without making a compromise in terms of quality. In order to benefit from an advantageous deal, you simply have to find a reputed supplier of dental equipment, committed to helping you create a well-equipped dental practice where you will be able to do your job safely and effectively. Dental chairs are one of the most important pieces in a dental practice; with the right dental chair, you can reduce downtime to the minimum and thus increase the profitability of your business. When looking for the right dental chair, you should focus on products that have already been tested by your peers and that have preserved an impeccable reputation over the years. Also, you should pay attention to the technical features of the chair, for a well-designed chair will enable the patient to enjoy the best comfort. In concrete terms, you should focus on dental chairs equipped with a double articulated and removable headrest, an armrest that can be easily moved out of the way, soft upholstery and safety features that will enable you to immediately stop the chair in case of emergency. The dental fit out expert will also help you choose the best sterilization and maintenance equipment, making sure that the products you select will enable you to effectively protect yourself, as well as your patients. In order to achieve impeccable results, you should shop for a high-quality disinfector, cutting-edge reverse osmosis water systems, a convenient and efficient bagging system, a high performance vacuum autoclave and, last but not least, a top quality sterilizer. All these elements will enable you to perform dental procedures in complete safety, without putting your patients at risk. Hence, it is vital that you give sterilization equipment the attention it deserves and that you choose reliable and effective products that will adequately protect your work environment. The dental lighting system is also a crucial component in a dental practice; with the right lighting equipment, dentists will be able to benefit from a high level of illumination, enabling them to provide exceptional patient care. If you want to benefit from premium lighting options that will provide easy access to your patients and instruments every time you perform a procedure, you should make an appointment with a reputed dental fit out provider. Consultants with numerous years of experience in the industry should be able to assist you, making sure that your dental practice will suit your style and working methods. To conclude, the power to make your dental practice an efficient, spotless and highly functional space is in your hands. We put at our clients’ disposal complete dental fit out ( https://dentalsurgeryrefubishment.com ) solutions designed to meet their specific needs. We invite you to visit our website to learn more about our reliable dental practice refurbishment ( https://dentalsurgeryrefubishment.com ) services or to contact us and let us equip your dental practice with the best technology on the market. (Added: Tue Jan 29 2019 Hits: 62 Rating: 0.00 Votes: 0) Rate It

• Extension Professional’s Clip-in Hair Extensions Launched in Harrods, London - Extension Professional founded by Louise Bailey specialises in creating lightweight clip-in extensions from finest human hair. The brand’s products are available online and they recently launched its incredible line of clip-ins in Harrods, London. “The overwhelming demand for our clip-in extensions drove us to distribute them in physical stores across London. Our stocks are also held in Harrods Hair & Beauty and Duck & Dry”, said a company spokesperson. He further added, “Our range of clip-ins is crafted by the founder of Extension Professional, Louise Bailey. She is also a renowned hair stylist and has worked with several celebrities and pop stars across the UK.” Extension Professional’s clip-in extensions have always had an incredible following thanks to their enviable thickness, extra volume and swishable length that comes with an undetectable, natural finish. This company’s extensions can simply be clipped into natural hair in under an hour. “Harrods, London is extremely happy to stock our selection because we create our extensions from ethically sourced, high-quality human hair. Our products feature a double-bar design with hundred and fifty gram of hair, which is layered over 2 user-friendly wefts that offer a seamless blend. As they come with soft clip-in attachments, they are comfortable to wear all day and do not damage natural hair. They are also easy to remove”, added the company’s spokesperson. The brand has launched 21 different shades of clip-in extensions in Harrods, London and the wefts are 16 inches. As their clip-ins are made of human hair, the extensions can be easily coloured, dyed or styled in any way that the user pleases. “We hope that extensions will have a permanent place in a woman’s hair care arsenal. This is why Louise works day and night to come up with innovative products.”, said a company executive before signing off. About the company: Extension Professional is the brainchild of London’s stalwart hair extension specialist, Louise Bailey. She has years of formal education and hands-on experience in developing the finest hair products. Louise sources the highest quality European hair to craft innovative products. The clip-in extension range is available online and across physical locations in London. Contact Extension Professional Tel: 020 3416 5136 https://extensionprofessional.co.uk/ Louise Bailey Conduit Street London W1S 2GB claire@extensionprofessional.co.uk (Added: Tue Jan 29 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Cleanroom Consumables Market Value to Reach US$ 13,000 Mn by 2026 - Cleanrooms are controlled environments with low levels of pollutants such as dust, microorganisms, and chemical vapors. Cleanrooms are used in a number of industrial processes, where pollutants can interfere and deteriorate the quality of production. However, complex and varied cleanroom regulations and increase in raw material prices are projected to hamper the growth of the global cleanroom consumables market in the near future. Read Report Overview: https://www.transparencymarketresearch.com/cleanroom-consumables-market.html The global cleanroom consumables market was valued at US$ 9,000 Mn in 2017 and is anticipated to expand at a CAGR of 5% from 2018 to 2026 to reach US$ 13,000 Mn by 2026. Increase in demand for modular cleanroom systems and advent of nanotechnology are likely to drive the global cleanroom consumables market during the forecast period. Major companies enter into distribution agreements to expand their footprint in the global market. Technological advancements and mergers & acquisitions are expected to propel the global cleanroom consumables market during the forecast period. For example, in February 2017, Ansell acquired Nitritex Limited, a U.K.-based company, which offers cleanroom and life science consumables. The company distributes its products in over 60 countries. Post the acquisition of Nitritex, Ansell also owned Nitritex’s flagship products BioClean and Omega. Based on product, the global cleanroom consumables market has been classified into cleanroom apparels, cleaning products, cleanroom stationery, wipers, gloves, and adhesive mats. The cleanroom apparels segment has been divided into coveralls, frocks, boot covers, shoe covers, bouffants, sleeves, pants, face masks, and hoods. The cleaning products segment has been categorized into cleanroom mops, buckets, wringers, and squeegees; validation swabs, and cleaning chemicals. The cleanroom stationery segment has been classified into papers, notebooks and adhesive pads, binders and clipboards, and labels. The wipers segment has been bifurcated into dry and wet. Based on application, the global market has been divided into electronics, pharmaceutical and biotechnology, aerospace and defense, academics and automotive, medical devices, and others. The academics and automotive segment is anticipated to expand at the highest CAGR during the forecast period. Cleanroom processing is employed in the automotive industry to manufacture and deliver safe and effective components due to high demand in automobile assembly lines. In terms of revenue, Asia Pacific dominated the global cleanroom consumables market in 2017, owing to growth of the food and beverage, food processing, pharmaceutical, biotechnology, and medical device industries. Rise in prevalence of contagious diseases and prominence of the domestic players are projected to drive the cleanroom consumables market in Asia Pacific in the near future. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3995 The report also provides profiles of leading players operating in the global cleanroom consumables market. Berkshire Corporation, KM, and KCWW are the major players operating in the market, offering products with proprietary technologies. Other players include Cantel Medical, Contec, Inc., DuPont, Micronclean, Ansell, Texwipe, Thermo Fisher Scientific, Inc., and Valutek. In June 2018, DuPont introduced Tychem gloves for chemical exposure protection. In the same year, Contec, Inc. introduced VertiKlean MAX range compact bucket system for cleaning and disinfecting in critical environments. DuPont entered into a partnership with Formosa Tafetta Company, a Taiwan-based new heated clothing company, in January 2018.  About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Jan 29 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Microbiology Testing Market- Cepheid to launch new TB test ultra-backed by WHO recommendation - Recent Developments Cepheid is an American molecular diagnostics company that develops manufactures and markets fully integrated systems for testing in the clinical market. The organization received CE-IVD clearance for Xpert HBV viral load and Xpress RSV test. Cepheid announces expanded access to Xpert family of virology tests in global regions with the greatest need. Cepheid Expands Respiratory Disease Portfolio with Xpert Xpress Strep A. To know more, read: https://www.marketdataforecast.com/market-reports/microbiology-testing-market-7376/ Market Segmentation Market Data Forecast published a report named Global Microbiology Testing Market it is currently valued USD 4.34 billion in 2018 and is projected to be growing at a CAGR of 11.80%, to touch USD 7.58 billion by 2023. Report segmented as: Product: • Instrument • Reagents Application: • Pharmaceutical • Clinical • Food Testing • Energy • Chemical and Material Manufacturing • Environmental Geographical Segmentation: The market has been geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. As of 2018, North America leads the market, accounting for the major stake of the global market share. Europe comes in second in terms of market share. Asia-Pacific is expected to outpace all other regions by clocking the highest CAGR during the forecast period Key Market Players: • Danaher Corporation • Becton • Cepheid • Abbott Laboratories • Bio-Rad Laboratories View sample and decide: https://www.marketdataforecast.com/market-reports/microbiology-testing-market-7376/request-sample The scope of the report: The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated. The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis of prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook on the market along with recommendations from industry experts on the opportunities for investment activity. What else? Apart from the syndicated report, our in-house team has expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions. Contact Info: Name: Mr. Abhishek Shukla Email: abhishek@marketdataforecast.com Organization: Market Data Forecast™ Address: Hyderabad, Telangana 500033, India. Phone: +1-888-702-9626 (Added: Tue Jan 29 2019 Hits: 8 Rating: 0.00 Votes: 0) Rate It

• Stem Cell Assay Market Key Developments Trends, Analysis and Forecasts Till 2023 - Stem cells have a remarkable potential to develop into different types of cells and are involved in the internal repair system of the body. Stem cell assays are the techniques for analyzing the living cells on the parameters of shape, size, besides others with the aim to measure biochemical and cellular functioning of the cells. Growing biotechnology sector and increasing Global burden of the diseases like cancer, diabetes, and others is the major driver for market growth during the forecast period. Additionally, growing healthcare expenditure and rising government support, boosts the market growth. However, stringent government policies, high procedural cost followed, and lack of awareness and skilled forces restrains the market growth during the projected period. Market for Global Stem Cell Assay is Estimated to grow at an Approximate cagr of 19.80% from 2017 to 2023. To Explore More, Get PDF Sample Copy @ https://www.marketresearchfuture.com/sample_request/5656 . Key Players for Global Stem Cell Assay Market GE Healthcare (U.K.), Promega Corporation (U.S.), Thermo Fisher Scientific (U.S.), Merck KGaA (Germany), Cell Biolabs, Inc. (U.S.), Hemogenix (U.S.), STEMCELL Technologies Inc. (CA), Bio-Rad Laboratories, Inc. (U.S.), Bio-Techne Corporation (U.S.), and Cellular Dynamics International Inc. (U.S.), and others. Segments for Global Stem Cell Assay Market The Global Stem Cell Assay Market is segmented on the basis of product, technology, assay, application, and end-user. On the basis of the product, the market is categorized into microelectrode arrays, flow cytometer, cell imaging systems, automated cell counter, kits, and others. The kits segment is sub-segmented into mesenchymal stem cell kits, induced pluripotent stem cell kits, umbilical cord stem cells, and others. On the basis of the technology, the market is segmented into microfabricated assisted technology microfluidics-based cell trap technologies, and others. On the basis of the assay, the market is segmented into cell viability & toxicity assays, cell identification assays, cell proliferation assays, cell apoptosis assays, and others. On the basis of the application, the market is segmented into the orthopedic & musculoskeletal spine, dermatology, cardiovascular, central nervous system, and others. On the basis of the end user, the market is segmented into biotechnology industries, research organizations, academic institutes, and others. Regional Analysis for Global Stem Cell Assay Market The Americas dominate the Global Stem Cell Assay Market owing to increasing adoption of new technologies and a huge patient population for diseases like diabetes, cancer, and others. The Global Stem Cell Assay Market in Europe is the second largest owing to the growing biotechnology sector and huge patient population. Additionally, increasing support by the government for research and development boosts the market growth. Asia Pacific region is the fastest growing market for stem cell assay owing to increasing awareness and rising healthcare expenditures within the region. Moreover, the presence of the developing economies like India and China have a developing biotechnology sector which fuels the market growth. In 2017. India biotechnology industries comprised ~800 related companies and was valued to be approximately around USD 11.6 billion in 2017. The Middle East & Africa has the least share in the Global Stem Cell Assay Market due to low per capita healthcare expenditure, lack of awareness, stringent government policies, and presence of poor economies, especially within the in the African region. The Middle East holds a majority of the Stem Cell Assay Market in the Middle East & Africa region. Browse Complete Report @ https://www.marketresearchfuture.com/reports/stem-cell-assay-market-5656 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com (Added: Tue Jan 29 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Phototherapy Market Staggering Double Digit CAGR Till 2023 - According to the study offered by Market Research Future (MRFR), the global phototherapy market is set to expand moderately at a CAGR of 4.6% during the forecast period 2017 to 2023. It is in high demand for reducing bilirubin levels that cause jaundice in newborns. The treatment also helps in the reduction of itching, inflammation, and enables increment of vitamin D production and bacteria-fighting systems in the skin. Thus, an upsurge in demand has been predicted for the therapy in the foreseeable future. The therapy is excessively effective in the treatment of skin diseases such as psoriasis, vitiligo, etc. According to a report published by the World Health Organization (WHO), the prevalence of psoriasis is on the rise since 2014 and affects a large percentage of the global population, regardless of gender and ethnicity. It is prognosticated to favor the expansion of the global phototherapy market over the assessment period. On the flip side to the increasing demand for phototherapy, the side effects such as skin rashes, dehydration, etc. are expected to check the growth of the market across the review period. Furthermore, the risk of eye damage if not protected properly is another major factor restricting the expansion of the phototherapy market. Get Sample PDF Illustration @ https://www.marketresearchfuture.com/sample_request/1844 Key Players for Global Phototherapy Market Some of the key players profiled in the report are GE Healthcare (UK), Natus Medical Incorporated (U.S.), MTTS ASIA (Vietnam), Beurer GmbH (Germany), Herbert Waldmann GmbH & Co. KG (Germany), Koninklijke Philips N.V. (Netherlands), PhotoMedex, Inc (U.S.), and VIA Global Health (U.S.). Market Segmentation: On the basis of devices, the global phototherapy market has been segmented into Firefly, fiber-optic blanket, fiber-optic band, and others. On the basis of indication, the phototherapy market has been segmented into skin diseases, jaundice, and others. Furthermore, the skin diseases segment has been sub-segmented into psoriasis, vitiligo, and others. On the basis of the end-user, the global phototherapy market has been segmented into hospitals & clinics, dermatology center, home care, and others. Regional Analysis for Global Phototherapy Market The Global Phototherapy Market, on the basis of region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas account for the maximum share of the global market and is expected to retain its market position through the forecast period. The rising burden of diseases such as jaundice, psoriasis, vitiligo, etc. is primarily driving the expansion of the phototherapy market in the region. In addition, other factors that are benefitting the healthcare sector such as the presence of developed healthcare infrastructure, rising healthcare expenditure, changing lifestyle and growing government support are expected to propel the proliferation of the market in the forthcoming years. Also, the consolidation of the key players in the region is likely to boost the growth trajectory of the phototherapy market. Europe, which is expected to secure the second spot in the global phototherapy market, is expected to exhibit healthy opportunities for growth through the assessment period. Investments are likely to flow towards the development of the market in developed economies such as Germany and France. This, in turn, has been prognosticated to augment the regional phototherapy market over the next few years. In addition, the accelerated research & development activities backed by the governments for the development of highly precise and effective treatments are poised to fuel demand for phototherapy in the region. Asia Pacific is a prominent regional market and is set to exhibit the steepest rise in the growth. The factors favoring the expansion of the phototherapy market include rising healthcare awareness, the presence of fast-developing economies, growing government support, and high demand for developed treatment methods. The Middle East & Africa is estimated to hold the least share of the global phototherapy market through the forecast period. The Middle East is expected to lead the regional market; however, the poor socio-economic conditions of the African regions remain the main laggard. Browse Complete Report @ https://www.marketresearchfuture.com/reports/phototherapy-market-1844 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com (Added: Tue Jan 29 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Pancreatic Cancer Market Key Manufactures Shares, Analysis and Forecasts Till 2023 - Rising rates in tobacco consumption, increasing cigarette smokers are likely to enhance the growth of Pancreatic Cancer Market. Additionally, rising prevalence of cancer, increase in intake of alcohol, growing obesity rates, and growing awareness pertaining to various treatment options available are propelling the market growth at a Global level. The Global Pancreatic Cancer Market is expected to grow at a CAGR of 8.1% during the forecast period 2018-2023. Get PDF Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/1638 Key Players for Global Pancreatic Cancer Market Some of key the players in the market are Pharmacyte Biotech Inc. (U.S.), OncoGenex Pharmaceuticals Inc. (U.S.), Oncolytics Biotech (Canada), Diffusion Pharmaceuticals (U.S.), Polaris Pharmaceuticals, Inc. (U.S.), Sun BioPharma, Inc. (U.S.), Midatech Pharma PLC (U.K.), Eli Lilly and Company (U.S.), Celgene Corporation (U.S.), F. Hoffmann-La Roche AG (Switzerland), Amgen, Inc. (U.S.), Novartis International AG (U.S.), Clovis Oncology (U.S.), and others. Segmentations The global pancreatic cancer market is segmented on the basis of types, treatment, and end user. On the basis of the type, it is segmented into endocrine pancreas cancer, exocrine pancreas cancer, and others. On the basis of the treatment, it is segmented into chemotherapy, surgery & radiation therapy, targeted therapy, biologic therapy, hormone therapy, and others. Furthermore, the chemotherapy is segmented into antimetabolites, anthracyclines, taxanes, and alkylating agents. The targeted therapy is sub-segmented into tyrosine kinase inhibitors and monoclonal antibodies. And the hormone therapy is sub-segmented into estrogen-receptor modulators, aromatase inhibitors, and others. On the basis of the end user, it is segmented into hospitals & clinics, research institute, and others. Regional Analysis for Global Pancreatic Cancer Market The Americas dominate the global pancreatic cancer market owing to well-developed technology, increasing patient with cancer, high health care spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region. Europe holds the second position in the global pancreatic cancer market owing to the government support for research & development and availability of funds for research. This is expected to continue to drive the European market over the forecasted period. For instance, countries like Germany and France are increasing investment in the healthcare domain. Asia Pacific is the fastest growing pancreatic cancer market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing demand for new treatment methods in countries like India and South Korea is likely to emerge as the fastest growing market across the globe. On the other hand, in the Middle East and Africa, pancreatic cancer has become a huge problem due to limited screening, ignorance of diseases, and poor access to treatment. Browse Complete Report @ https://www.marketresearchfuture.com/reports/pancreatic-cancer-market-1638 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com (Added: Tue Jan 29 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Fastest and Safest Global Air Ambulance Srinagar at manageable-cost - January 29, 2019 - Global Air Ambulance, A company which is well-equipped and well-furnished and always ready to help the needy and serious at a time. Global Air Ambulance Service provides all the ICU emergency facilities which are very helpful and accomplice for the serious patients from the initial city to destination under the full and advanced supervision. It is providing them with the very economical and low budget emergency patient transfer facilities. The specialty of Global Air Ambulance A huge panel of ICU/CCU and Ventilator specialist MD doctors A great channel of qualified and experienced paramedical technicians Hi-tech Medical Ambulance Services which is well-furnished Emergency Evacuation Services with the newest equipment Booking of serious call anytime from anywhere in India Charter Ambulance Services The fastest emergency services provider Monitoring and control of patient by MD Doctor during transfer Global Air Ambulance Service in Srinagar offered at a low price without compromising with the quality. Our features include passionate, qualified, and dedicated medical team, genuine advice, bed to bed and Peer-to-peer evacuation facility, with no hidden and extra charges and much more quality based amenities for the patients. Some Advantages of Global Air Ambulance Service in Srinagar Round the clock available on phone to offer multiple emergency services any time and from anywhere The best team of medical executives and qualified MD Doctors Great coordination of medical team from the time of booking to furnish of the evacuation Global Air Ambulance Service from Jodhpur team remains on toe and rush for the location as soon as a distress call is received in our control room. The fastest ICU setup we have to ensure the safe transportation of a critical patient. More@ https://www.globalairambulance.in/air-ambulance-services-in-jodhpur/ (Added: Tue Jan 29 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Biomarkers Market Opportunities, Drivers, Manufacturers, Analysis and Forecasts Till 2023 - Biomarkers have a broad spectrum of clinical uses and in medicine. It is critical in both diagnostics and ascertaining the best treatment route. Largely used for cancer, biomarkers and biomarker technology is growing in use and is experiencing increasing demand. Market Research Future has performed a detailed study on the market and all its factors to ascertain that the market is likely to witness a CAGR of 9% during the forecast period of 2018 to 2023 and reach an estimated USD 78 bn by the end of the review period. Biomarkers are effective for various medical applications besides diagnosis. They can be helpful in disease prevention, drug target identification, and several others. The growing global prevalence of chronic diseases, neurological disorders & diseases, and cardiovascular diseases; these are the result of growing urbanization, and changing global environment. The high demand for biomarker technologies is driven primarily by the advancement of medical technologies, and the growing investments in healthcare and medical sectors across the world. Moreover, governments and the associated government health, medicine, & drug bodies are highly supportive of biomarkers and biomarker technologies research and development. The increasing use of biomarkers in an effort to produce accurate diagnoses is additionally expected to support market growth over the assessment period. To Get Sample Report visit https://www.marketresearchfuture.com/sample_request/1941 The high capital investments required for the development of biomarkers and discovery of the same combined with the high cost of the use of biomarker technology is expected to restrain market growth. However, growing research and advancement in the field has brought biomarker technology a long way and is expected to contribute significantly to a wide scope for future growth. Key Players for Global Biomarkers Market Market Research Future (MRFR) recognizes the following companies as the key players in Biomarkers Market: There are plenty of large and small market players which operate in this market all over the globe. MRFR's analysis of the competitive landscape of the market reveals several key players that are driving the market with their research & development, patent filing and use of other market driving strategies. Prominent market players include Waters Corporation, Danaher Corporation, Shimadzu Corporation, Seimens Healthcare, Bio-Rad Laboratories, and Abbott Laboratories among others. Segments for Global Biomarkers Market MRfR's segmental assessment has been performed on the basis of product type, profiling technology, disease application, research areas, and region. By product type, the market is segmented into instruments, consumables, services, and software/informatics. Based on profiling technology, the market is segmented into PCR, imaging technology, Biomarkers, mass spectrometry, chromatography, NGS, cytogenetics, and other technologies. Further sub-segments are available for Biomarkers in the report. By disease application, the market is segmented into infection diseases, neurological, cardiovascular disorders, autoimmune diseases, cancer, and other disorders. Based on research areas, the market is segmented into proteomics, metabolomics, genomics, and other research areas. Metabolomics is sub-segmented to include lipidomic and others. Regional Analysis for Global Biomarkers Market The global biomarker technologies market is analyzed globally and divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Led by North America, the Americas account for the largest share of the global biomarker technologies market. There are a high prevalence of cancer, diabetes, cardiovascular, neurological, and autoimmune diseases which have led to a skyrocket in demand for effective diagnostic and treatment technologies. Moreover, the presence of steadily rising geriatric population , increased initiatives from the government, increasing funding for research and the growing availability of favorable reimbursement policies is expected to drive demand, and development of the technology. High growth is expected from the region in the coming years as health care spending has risen and the availability of ample opportunities for growth. Meanwhile, the Asia-Pacific is projected to witness rapid growth at the highest CAGR, globally. The presence of a massive population pool, with growing incidences of chronic diseases, has proven to be a significant driver of growth. China and India are two of the most highly affected countries with a high diabetic population. These countries are fast emerging markets, due to the highly supportive government policies surrounding healthcare, increased funding for investment, and health care and the growing, rising disposable income which has led to increased healthcare spending by patients. Browse Complete Report @ https://www.marketresearchfuture.com/reports/biomarker-market-1941 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com (Added: Tue Jan 29 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Worldwide Pain Management Device Market Ready to Set outstanding Growth from 2019 to 2023 - The Pain Management Devices Market is getting excellent traction with booming healthcare sector. Disabilities caused by pain is frustrating and a liability for patients as it halts the normal efficacy of human being. Pain management devices are designed to mitigate or obliviate such pains and provide patients a stress-free life. The global pain management devices market is banking on that aspect and showing potentials to chart a course where its valuation would reach to USD 5.81 billion mark by 2023, asserts Market Research Future (MRFR). The report further predicts a 7.2% CAGR during the forecast period (2016-2023) and focuses on possible market drivers such as rise in mortality rate that also ensures a huge patient pool who are susceptible to wounds and contracts pain easily. Furthermore, increasing research & development activities and rising pain rehabilitation centers are bound to impact the pain management devices market with a great gusto. Despite such efforts made by the healthcare sectors, the global pain management devices market can feel bottlenecked by the high cost involved with it. But the market can always find hope in companies making efforts to launch new products. The strategic move can invigorate the pain management devices market and hold it back from sliding down during the forecast period. To Get Sample Report visit https://www.marketresearchfuture.com/sample_request/1504 Industry News Medtronic of Canada Ltd. has received a license from Health Canada for its Intellis™ platform. This includes the world's smallest implantable spinal cord stimulator (SCS) for the management of few types of chronic intractable pain. Given the issues of opioid abuse prevalent in the country, it has become mandatory for Canadians to have access to new non-opioid treatment options. One of these options includes adoption of SCS that provides effective and long-term pain relief while being a treatment option for patients who are interested in trying a non-drug alternative. Key Players for Global Pain Management Device Market The Global Pain Management Devices Market thrives mostly on strategic moves that include merger, acquisition, collaboration, product launch and others. It benefits both the concerned company and the market. Johnson & Johnson and Synthes recently announced their merger agreement in their attempt to create the world’s most innovative and comprehensive orthopedics business. This collaboration can assist the pain management devices market growth. NeuroMetrix, in 2018 launched Quell 2.0, a 100% drug-free device that can be really effective in managing pains. Quell app has also been designed to make its operational facilities simple. The product is also smaller in size. Grunenthal and KU Leuven joined hands in 2018 to develop a non-opioid pain treatment for painful diseases with a high unmet medical need. Eminent players in the Global Pain Management Devices Market include Codman and Shurtleff, Inc. (U.S.), Stryker Corporation (U.S.), Hospira Inc. (U.S.), Smiths Medical (U.K.), Baxter International Inc. (U.S.), Boston Scientific Corporation (U.S.), Medtronic Plc (U.S.), St. Jude Medical (U.S.), Bio-Medical Research (BMR) Ltd. (U.K.), Kimberly-Clark Corporation (U.S.), DJO Global LLC (U.S.), B. Braun Melsungen AG. (Germany), Pain Management, Inc (U.S.), and others. Segments for Global Pain Management Device Market The Global Pain Management Devices Market can be segmented by stimulators, pumps, ablation devices, and application. By stimulators, the pain management devices market can be segmented into neuromodulator devices and transcutaneous electrical nerve stimulation (TENS) devices. Neuromodulator devices can be further sub-segmented into spinal cord stimulator, intrathecal pain pump, peripheral nerve stimulator, dorsal root ganglion stimulation and other. By pumps, the pain management devices market can be segmented into analgesic infusion pumps and other. Analgesic infusion pumps segment is further segmented into patient control infusion pumps, external infusion pumps, intrathecal infusion pumps and other. Based on ablation devices, the pain management devices market can be further segmented into microwave devices, cryoablation devices and others. On basis of application, the pain management devices market includes cancer pain, musculoskeletal pain, migraine, and others. Regional Analysis for Global Pain Management Device Market As per the report, the Global Pain Management Devices Market is spread across the regions of North America, Europe, Asia Pacific (APAC), and Middle East and Africa (MEA). North America holds the maximum market share for pain management devices followed by Europe. The robust growth has been aided by huge investment and development in research & development. Moreover, the healthcare industry in the region has outperformed its peers from other regions which has ensured a smooth sailing ahead for the regional pain management devices market. Browse Complete Report @ https://www.marketresearchfuture.com/reports/pain-management-devices-market-1504 The APAC is growing at the fastest growth rate with the continuous efforts of the governments in the region to revamp the healthcare sector which ensures growth prospects of the market. Europe observes a highly mature market in terms of revenue and size on account of favorable reimbursement, development of novel neuropathic pain management device and a large patient population base. Increasing healthcare awareness, along with growing healthcare expenditure in the region, are also playing their part in taking the market ahead. The MEA markets is a bit topsy-turvy due to weak economic growth and lack of sophisticated healthcare infrastructure. However, the region is profiting much from government and private initiatives who are exploring the untapped possibilities for further growth. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com (Added: Tue Jan 29 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• mejor master de osteopatia - La Osteopatía Oftalmológica La mejor formación de osteopatía sigue siendo una gran desconocida en el mundo de la oftalmología, pero sin embargo cada vez es más común su aplicación en la prevención y la mejora de la visión. La mejor formación de osteopatía, ofrece muy buenos resultados en el tratamiento de la miopía, la hipermetropía, el astigmatismo, el estrabismo o el glaucoma, entre otros. Causas de la miopía, hipermetropía y astigmatismo En el tratamiento de la miopía, la hipermetropía y el astigmatismo, la mejor formación de osteopatía mejora los defectos de la refacción de la luz, trabajando cada uno de los huesos que forman la órbita y su conjunto de la lente ocular. El síntoma para detectar la deformación del globo ocular es la visión borrosa o distorsionada. Las causas principales que pueden originar esta deformación suelen ser por acciones durante el parto o el embarazo. También se puede producir por una compresión de los huesos craneales que desarrollen alteraciones de músculos, nervios o arterias, provocando defectos en la visión, así como el enfoque del ojo. La mejor formación de osteopatía nos enseña que en el caso del astigmatismo, debido a la irregularidad en la curvatura, la forma esférica se altera cambiando a una forma más elíptica u ovalada impidiendo el enfoque entre lejos y cerca. El astigmatismo puede asociarse en algunos casos a la miopía, hipermetropía o por otros motivos aislados. La mejor formación de osteopatía como tratamiento Con la osteopatía trabajaremos cada hueso craneal y de la bóveda ocular con el objetivo de liberar todas las tensiones suturares, musculares, arteriovenosas o estructuras nerviosas. De este modo, devolveremos al ojo su forma esférica y su funcionalidad, así como una correcta posición en cuanto al eje del ojo. Es importante comenzar a tratar al niño desde edades tempranas, a ser posible antes de los siete años para evitar complicaciones.Otros problemas derivados de la vista como en el caso de las cataratas tempranas o la presbicia, la mejor formación de osteopatía puede ayudar a nivel de la vascularización del ojo, mejorando el deterioro de la córnea. La mejor formación de osteopatía trabaja como drenaje favoreciendo el movimiento de la sangre y disminuyendo considerablemente la presión interna del ojo, en el caso del glaucoma, llamada tensión intraocular.Además, actúa en la circulación de la sangre, de la linfa, del líquido cefalorraquídeo y libera la presión de los nervios y vasos sanguíneos que rodean a los ojos. El osteópata calificado valorará mediante diferentes test las suturas craneales y paquetes vasculonervioso.Trabajaremos zonas de disfunción mediante técnicas articulares, viscerales, membranosas o posturología, sin olvidarnos de las conexiones con el resto del cuerpo. Todo ello complementado con ejercicios y terapias especializadas, encontradas en la mejor formación de osteopatía. La mejor formación de osteopatía es una terapia manual que se basa en un riguroso y completo enfoque hacia la anatomía. En definitiva, la osteopatía estudia el cuerpo desde su globalidad, esto es, desde la estructura ósea, muscular, y también visceral. Los fisioterapeutas osteópatas insisten en que el cuerpo humano es una maquinaria muy compleja, que no siempre comprendemos y que la mayoría de las ocasiones forzamos en exceso. Combinando los conocimientos médicos de estas tres áreas, aseguran, se pueden realizar tratamientos más intensos y efectivos sin necesidad de recurrir a químicos (en referencia a los medicamentos que recetan los médicos). (Added: Tue Jan 29 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Advanced Wound Management Market Overview 2018 by Latest Technology in Industry & Forecast - 2028 -

  A new study by the company titled 'Advanced Wound Management Market: Global Industry Analysis 2007-2017 and Opportunity Assessment 2018-2028' lists key strategies employed by companies involved in advanced wound management to stay sustainably profitable in the long run in the market. North America is the prime region for advanced wound management products as healthcare practitioners now prefer advanced wound management products over traditional products in the region. APEC advanced wound management market is expected to grow due to rising patient pool and rising geriatric population in major economies, such as Japan. Increasing demand, availability of cost-effective treatment options and rising spending on healthcare in developing regions are some of the important factors creating a robust platform for the growth of the advanced wound management market.

  Advanced wound management market report reveals that as compared to traditional wound management products, advanced wound management products are specially designed for the treatment of complex wounds. They perform various functions, such as maintaining a stable temperature around the wound, allowing oxygen flow, protecting the wound from infection, removal of dead tissues and relieving pain during dressing changes. Advanced wound management involves silver based product which is a very effective modality for prevention or treatment of infection caused due to various bacteria, viruses, fungi and molds. It has very few side effects and is thus, finding space in advanced wound management products. That apart, biological wound products helps to treat multiple complex wounds in an effective manner.

  Growing awareness regarding personal health and hygiene is also expected to boost the demand for advanced wound management products. Patients have become aware and pro-active about their health and are willing to seek physicians’ advice at an early stage. Also, growth in per capita disposable income is further encouraging people to spend more on their health-related needs.

  Request Sample Report @  https://www.futuremarketinsights.com/reports/sample/rep-gb-8422 

  Health care providers and physicians in developing regions are reluctant to adopt advanced wound management products. It has also been observed that the adoption rate of advanced wound management products in Europe is low as compared to the U.S. High cost of advanced wound management therapy has been the essential factor for the reluctance of physicians to adopt these technologies.

  There are various bioengineered skin products available in the advanced wound management market; however, the cost analysis of these products reveals that a normal dressing costs around US$ 3.25 whereas bioengineered skin products costs around US$ 650. Due to the significant difference in cost, patients and healthcare providers are reluctant to adopt advanced wound management products. This has resulted in stagnant sale of novel technologies, especially those that haven’t seen enough advertisements or public knowledge.

  Advanced wound management products face still competition from traditional wound care products. Advanced wound management product include products ranging from advanced wound dressings and wound contact layers to superabsorbent dressings and negative pressure wound therapy devices. 

  Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-8422

  Hospitals, clinics, ambulatory surgical centers, skilled nursing facilities and other facilities are the primary point of contact for patients needing such advanced wound management products.

  The advanced wound management market is a lucrative market. Regions, such as APEC and China, still enjoy relevance and dominance of local players. These local players, as a matter of fact, are also affecting the growth of the advanced wound management market in the region. However, the global advanced wound management market is consolidated in nature, with key players enjoying significant position in the advanced wound management market. Some of the key companies present in the advanced wound management market and included in this study are B. Braun Melsungen AG, Mölnlycke Health Care, ConvaTec Group plc., Coloplast A/S, SIGVARIS, Acelity L.P. Inc., 3M, BSN Medical, Ethicon Inc., Medline Industries, Inc. and Smith & Nephew PLC.

  (Added: Tue Jan 29 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Stem cell treatments hospital in Bangkok - Welcome to AlMurshidi Medical Agency Plastic surgery in Thailand - We offer the whole range of affordable plastic surgery packages in Thailand. Book your Free consultation today. We work hard to make your medical or cosmetic treatment visit to Thailand as pleasant as possible, with an understanding team of professionals and dedicated customer service who put your needs first. What make us different than others,that we continue expanding our network and offers, as we work with current and new medical and beauty providers, we will always offer you several options and plans, to make sure your needs are met. Non-Surgical Aesthetic or non-surgical treatment We offer a wide range of aesthetic beauty treatments such as Laser rejuvenation, anti-aging and non-invasive fat removal. Minimally invasive, non-surgical medical aesthetic treatments have recently grown in popularity. Specialist beauty treatments such as Botox injections, laser hair removal, dermal fillers, laser skin rejuvenation and chemical peels have been developed to treat wrinkles, acne and sun damaged skin, and to remove unwanted hair and thread veins. Discover the huge variety of treatments available. Medical Treatments Medical Treatments in JCI accredited Hospitals Affordable Surgical Treatments in Thailand We thrive in providing you with the best medical experience. Almurshidi Medical Agency pride in providing best online quotation to a wide variety of medical services. Whether it’s a pain relief or a completely different treatment, our specialized staff is right here for you. It is a one-stop medical agency for all your medical tourism needs. Almurshidi Medical Agency takes pride in providing the best medical tourism services in a friendly yet professional environment. We are a proud Thailand medical agency representing more than 15 hospitals, medical centres, and clinics. Our team have professionals that are connected with the doctors and clinics to give you best on ground support in Thailand. Our company have link with diversified healthcare centres that use the latest technology in surgical and various other medical procedures. We reduce your research work and create happiness by giving you affordable medical and cosmetic estimate before you fly to Thailand. photodune-818998-white-collar-worker-sEye Lasik Surgeryhealthy breakfastHealth Check-uphealthy breakfastLaser Hair Removalphotodune-2230626-nice-female-sLaparoscopic Band and Sleeve Surgery Medical treatment in Thailand Travelling to Thailand for medical treatment is a growing trend due to many factors. Often seen as a place for relaxing in the sun, Thailand is also one of the leading destinations for Medical Tourism in Asia (official estimates state over 1,000,000 people travelled to Thailand for treatment in 2015). From heart, spine, and cancer surgeries and treatments to as easy as teeth whitening, the chance to combine your hospital surgery or treatment with a holiday is seen by many people as a far better option than staying home. It makes sense when you consider the vast experience of dealing with foreign visitors, excellent customer service and world class hospitals Thailand – and Bangkok, in particular. visit for more information:http://almurshidimed.com/ (Added: Tue Jan 29 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Hydrocephalus Shunt Market SWOT Analysis to 2028 Top Companies, Analysis & Forecast -

  Future Market Insights foresees significant growth opportunities in hydrocephalus shunt market, considering the new-age development of smart shunt technology, while delivering advance diagnosis of cerebrospinal fluid (CSF), control, and communication, on the basis of sensors, telemetry, and feedback controls. Increasing focus on developing such smart shunt technology, is anticipated to prove favorable for the hydrocephalus shunt market—showcasing an otherwise sluggish landscape through the forecast period of 2018-2028, as per FMI’s analysis.

  The research intelligence report offers a deep-dive view of the global hydrocephalus shunt market—predicted to expand at a rather sluggish rate of 2.3 percent, reaching a valuation of US$ 498.6 Mn in 2020.

  “Stringent regulatory policies is a key factor severely impacting the growth of hydrocephalus shunt market. In addition, mechanical risks including leaks, migration, obstruction, and discontinuity and biological complications including infection, abscess, pseudocyst, heamotoma, and peritonitis associated with shunt implants, is also a key factor contributing to the market’s slow-moving growth. Other contributing factors could include high surgery costs and shortage of trained neurologist—specifically reported in countries like Australia, Canada, Ireland, U.K, and New”, explains a senior analyst from the Healthcare domain. The analyst further explains that shunt blockage and malfunction are two common complication associated with stunt implants—blockages occurring in nearly 31 percent patients. Moreover, such risks and complications often result in a number of hydrocephalus shunt revision surgeries, further creating a notable demand for hydrocephalus shunt.

  Request Sample Report @  https://www.futuremarketinsights.com/reports/sample/rep-gb-7756 

  FMI offers key insights on the global hydrocephalus shunt market

  • Hydrocephalus valves segment is expected to hold a massive value share of nearly 85 percent.

  • Within the Hydrocephalus valves type, adjustable pressure valves is likely to witness maximum adoption in hydrocephalus shunt surgeries.

  • Highest growth potential exists in North America, with an attractiveness index of 2.6 during the forecast period. Such adoption trend is expected to be followed in Western Europe—the second most lucrative market, showcasing interesting profit possibilities.

  • By age group, pediatrics and infants segment will report maximum adoption of hydrocephalus shunt.

  • Ventriculoperitoneal will remain the most preferred procedure, pushing maximum revenue in the global hydrocephalus shunt.

  Key Market Influencers: Technological Advancements and Awareness Campaigns for Hydrocephalus

  Considering the complexity of hydrocephalus shunting along with adjustments of cerebrospinal fluid draining, manufacturers of hydrocephalus shunts are increasingly introducing programmable and anti-siphon shunt valves—aimed at regulating drainage pressure and flow. The new technologies are indicated to eliminate the need for surgery revisions as a result of complications. The cerebrospinal fluid management technologies are likely to witness increased adoption in the coming years considering its utility in reducing siphon effect over cerebrospinal fluid drainage. Programmable pressure valves are gaining prominence versus fix pressure valves owing to its external features using specialized magnetic devices that helps in modifying opening pressure of valves.

  Additionally, demand for hydrocephalus shunts is slated to increase given the increasing number of government and private initiatives to spread awareness vis-à-vis hydrocephalus. Hydrocephalus Association, for instance, and its focus to conduct more hydrocephalus awareness campaigns and programs, with increased investments in research initiatives targeted at improving cure and treatment avenues for Hydrocephalus. Through its campaign ‘Roadmap to a Cure’, the organization, by 2020 is expected to invest US$20 and drive more research and support associated with hydrocephalus.

  Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-7756

  In the highly consolidated hydrocephalus shunt market, product and pricing power lies in the hand of top three players—reigning over nearly 84 percent of the total revenue share in the global hydrocephalus shunt market. Contributing nearly US$ 389 Million, the top three players include Medtronic Plc., Integra LifeSciences Corporation, and B. Braun Melsungen AG. Key forward market strategies include- viz. Efforts to gain regulatory approvals, geographic expansions in emerging economies, production capacity expansion, increased investments in R&D, and acquisitions to solidify global position in neurosurgery and regenerative technologies.

   ^pop (Added: Tue Jan 29 2019 Hits: 107 Rating: 0.00 Votes: 0) Rate It

• For the best nursing help in the country choose Quality care - Quality Care is a leading nursing staffing agency which offers great care services for old age people and disables people. Quality care is offering the best care services to growing aged people and disabled people who required great attention and care. We are providing you with quality care services all over Australia, and we have facilities like acute care, community care, disability care and aged care within affordable prices. The services depend on our professionals who are working with a brilliant mindset of presenting you the best. Our team is doing so much hard work to full fill the requirements of our patients, and we have the experts who are doing these jobs. We have the expertise qualities of nursing staff in our agency, and we are presenting best Nursing staff agency to our clients. Our nursing staff is doing fantastic thing by containing with simple plans and offering simplest & easiest things to our patients. We have different ideas of working, and we are sticking to our best intends to produce the best stuff to you. Our agency is providing Aged care nursing services to our patients, and we are presenting the best services all over Australia to you. Our nursing staff has extensive knowledge about their work, and they are always increasing their knowledge level. Quality care has a huge name in nursing services, and we have a reputation of serving with best for our clients. We have the machines and the peoples who are connecting with our patients and that are why we are the best in this business. We have completed successful so many years in the caring industry, and we are very good at doing our job done. We are presenting Acute Care Nursing all over the place, and we are proud to full fill all the requirements of our patients. We are behaving humble, pleasant and good with our patients and because of these things people are selecting us for best nursing helps. (Added: Tue Jan 29 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• San Clemente Dentist Who Cares About Children - San Clemente, CA -- Tuesday, January 29, 2019 -- All the advances in dental health are worthless if children people are not taught the importance of dental health at a young age. It's a tough thing for a young person to undo if they have a negative impression of the dentist. Statistics show that children who establish a relationship with the dentist at a young age are far more likely to maintain optimum dental health with regular visits to the dentist throughout life. Unfortunately, dental care is not something included in any type of national dental program in the USA. Why this is so is another topic altogether. Safe to say that given this reality, it is incumbent upon the parents to fill in this gap by ensuring children have nothing but positive, comforting memories of the dentist, and the sooner and more often this is done, the greater the long-term benefit. Dr. Eric Johnson is a kid-friendly San Clemente dentist with three little ones in the house, thanks to this, you can bet the chair-side manner provided to children is finely-tuned to deliver just the right amount of importance, respect and ease. And with it, the important lesson of dental health playing a large part in one's overall health, A priceless lesson indeed. And this is not just any dentist but one with local recognition in numerous local polls and publications; 5-star reviews almost exclusively from patients going back years; unmatched experience and schooling that completes the package. That package being superior dental care for folks of all ages with an emphasis on kid-friendly dentistry because the future holds many surprises and having superior health is the best way to plan for it. Parenting is difficult enough these days. Giving children the tools to be their best selves is one of the things we can do that has no downside with only lasting benefits. A relationship with dental health established at an early age is a great foundation in health to pass along to the next generation. Give Dr. Johnson a call today to drop by and meet the doctor for the first step in a life long appreciation for the dental health of your family. This kid-friendly dental office is putting the call out to all San Clemente families seeking a special dental experience. Make the call to drop by the office with the little ones for a "meet-and-greet" with the doctor. Call today: (949) 493-9311. Dr. Eric Johnson, DDS Kid-Friendly San Clemente Dentist 647 Camino De Los Mares, Ste. 209 San Clemente, CA, 92673 Phone: (949) 493-9311 Website: http://www.drericjohnson.com Email: smile@drericjohnson.com (Added: Tue Jan 29 2019 Hits: 4 Rating: 0.00 Votes: 0) Rate It

• Body Protection Equipment Market to Witness Strong Growth, Registering 6.6% CAGR During 2017-2022 - Body protection equipment includes different types of protective clothing, helmets, goggles, etc., in order to provide protection against various injuries, accidents, and infections to the workers. Various safety rules and regulations in different industries are expected to drive the demand for body protection equipment. Regulatory bodies such as OSHA, NFPA, and NIOSH have also made it mandatory to focus on safety and security of workers. Hence, increasing number of sectors such as manufacturing, oil & gas, pharmaceuticals, transportation, etc., are providing various protective equipment to workers. Companies are also demanding high-quality protective equipment that can last for a long time even after multiple uses. Protective wear for protection against radiation is also gaining popularity. Read Report Overview: https://www.transparencymarketresearch.com/body-protection-equipment-market.html Moreover, with the technological advancements, the process of development and material used in developing protective equipment has also changed. Manufacturers are using new and lightweight materials, and integration of sensors is also gaining momentum to offer high-level of safety and protection. The need for protective equipment to provide protection against flash fire at the workplace has also increased for both electric and gas operations. As per the latest report by Transparency Market Research (TMR), the global market for body protection equipment is likely to witness strong growth, registering 6.6% CAGR during 2017-2022. The market is also estimated to bring in US$ 2,901.4 million revenue by 2022 end. Compared to the various products in the body protection equipment, laboratory coats are likely to be one of the top-selling products. By 2022 end, laboratory coats are projected to surpass US$ 900 million revenue. Meanwhile, coveralls are also anticipated to witness healthy growth during 2017-2022. Increasing risk of working with hazardous chemicals is driving the demand for laboratory coats. Region-wise, North America is likely to emerge as the largest region in the global market for body protection equipment. Rising concern towards workplace fatalities and associated risks are driving the market growth in the region. Moreover, the presence of tech companies is leading towards innovation in body protection equipment. Competitive pricing and product differentiation are also the factors driving body protection equipment market in North America. Increasing prevalence of various diseases is also leading to the research on developing new body protection equipment for medical personnel in North America. Europe and Asia Pacific Excluding Japan (APEJ) are also likely to have a significant growth due to rapid industrialization, growing number of new projects in oil and gas and construction sectors. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=34979 The report offers a detailed profile on various major market players in the global market for body protection equipment. These players are 3M Company, Honeywell International Inc., E. I. du Pont de Nemours and Co, Cooper Tire & Rubber Co., Kimberly-Clark Corporation, Cintas Corporation, Ansell Limited, Lakeland Industries, Inc., Radians, Inc., and Alpha Pro Tech, Ltd. These players are focusing on entering into a partnership and mergers and acquisitions to develop advanced protective equipment and to expand geographically. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/  ^pop (Added: Tue Jan 29 2019 Hits: 103 Rating: 0.00 Votes: 0) Rate It

• Veterinary Chemistry Analyzer Market - Prevalence of Zoonotic Diseases to Propel the Market Growth - Growing population of animals and surge in adoption of pets is expected to impact growth of the global market. With the increasing adoption of pet, demand for healthcare maintenance and pet insurance will continue to increase. Prevalence of zoonotic diseases has led to surge in awareness regarding animal healthcare. Growing need for animal healthcare will continue to rev up demand for veterinary chemistry analyzer in the global market. Moreover, increasing number of veterinary practitioners is likely to boost sales of the veterinary chemistry analyzer in the global market. Bound to these factors, the global veterinary chemistry analyzer market is expected to witness significant growth during the forecast period. Read Report Overview: https://www.transparencymarketresearch.com/veterinary-chemical-analyzers-market.html Conducting hematology tests has continued to fuel demand for the veterinary chemistry analyzer globally. As the need to maximize the testing flexibility and delivering accurate results arises, demand for the veterinary chemistry analyzer is expected to rev up during the forecast period. Preference for consuming animal-derived food products will continue to increase in the food industry. Imposition of FDA regulations against contamination and illegal residue in the edible animal products has further contributed towards growth of the global veterinary chemistry analyzer market during the forecast period. Bound to these factors, demand for veterinary chemistry analyzer is expected to increase in the global market. Prevalence of the zoonotic diseases is further expected to contribute towards growth of the global veterinary chemistry analyzer market. According to recently published report by CDC, every year tens of thousands of Americans will get sick from zoonotic diseases that spreads between animals and people. Salmonella infection, E. Coli infection, chickungunya, dengue and malaria are some of the common and severe zoonotic diseases. According to World Health Organization (WHO), malaria caused 212 million clinical episodes and 429,000 deaths in 2015. As the need for various control measure for the zoonotic diseases arise, demand for the veterinary chemistry analyzers is expected to increase. Surge in demand for convenient and cheap rapid diagnostic tests is expected to impact growth of the global veterinary chemistry analyzer market positively. Growing preference for animal derived food products, demand for consumables continue to increase in the global market. On the basis of product type, the consumable segment is expected to generate significant revenues, accounting for a value of over US$ 180 Mn by the end of 2022. On the other hand, the glucometer product type segment is expected to register the highest CAGR throughout the forecast period. Based on application type, the veterinary hospitals segment is expected to represent the highest revenue growth, recording a value of nearly US$ 180 Mn by the end of 2017. The veterinary hospitals application type segment is further expected to register a robust CAGR through 2022. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=34976 Leading market players operating in the global veterinary chemistry analyzer market include Abaxis, Inc., Alfa Wassermann, Inc., Arkray, Inc., Biochemical Systems International Srl, Chengdu Seamaty Technology Co., Ltd., Diasys Diagnostic Systems GmbH, Elitechgroup, Eurolyser Diagnostica GmbH, Heska Corporation, Idexx Laboratories, Inc. and Randox Laboratories Ltd. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Jan 28 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Liver Transplant in India - Liver is a fundamental part for people; it assumes a significant job in digestion process. In the event that the liver is harmed using any and all means the injured individual can't endure. The best alternative for him/her future Liver Transplant. The article Liver Transplant in India involves data with respect to Liver working, indications of liver disappointment, liver gift, and Liver medical procedure. Expectation this article can convey mindfulness with respect to liver transplant to all peruses. (Added: Mon Jan 28 2019 Hits: 49 Rating: 0.00 Votes: 0) Rate It

• Liver Transplant in India - Liver is a fundamental part for people; it assumes a significant job in digestion process. In the event that the liver is harmed using any and all means the injured individual can't endure. The best alternative for him/her future Liver Transplant. The article Liver Transplant in India involves data with respect to Liver working, indications of liver disappointment, liver gift, and Liver medical procedure. Expectation this article can convey mindfulness with respect to liver transplant to all peruses. (Added: Mon Jan 28 2019 Hits: 24 Rating: 0.00 Votes: 0) Rate It

• Tumor Ablation Market to Grow at 12.2% CAGR Between 2017-2024 - The market is anticipated to exhibit an exponential growth in the years to come. Rapid adoption of new type of treatment to fight cancer with better efficiency of tumor ablation against traditional therapies is favoring the tumor ablation market. Apart from this, increasing public awareness programs in order to detect cancer at a very first step along with funds provided by government of various countries for cancer research, particularly in developed countries is stoking the tumor ablation market. Read Report Overview: https://www.transparencymarketresearch.com/tumor-ablation-market.html However, it has been noticed that the exorbitant cost of tumor ablation techniques coupled with constraint subsidy scenarios is deterring the growth of the global tumor ablation market. The global tumor ablation market is classified on the basis of disease indication, technology, geography, and end user. On the basis of technology, the market is segregated into high-intensity focused ultrasound, radiofrequency ablation, microwave ablation, laser interstitial thermal, cryoablation, and others. Amongst them microwave ablation is the most popularized technology among the healthcare sector. Minimal side effects and less duration of therapy has made microwave ablation more favored technology. Cryoablation technology is the second most used technology after cryoablation. However, it has been noticed radiofrequency ablation technology is at present leading the market owing to the prolonged rise in liver cancer cases among population all over the world. Radiofrequency ablation technology held a whopping 35.6% of the market share in recent years. On the basis of disease the, the global tumor ablation market is bifurcated into lung cancer, kidney cancer, breast cancer, bone cancer, prostate cancer, liver cancer, and others. Out of these, case of lung cancer is likely to grow at a staggering rate owing to rise in pollution and cigarette smoking level. It is predicted that this segment is likely to be valued at US$373.7mn by the end of the forecasts period. However, on the flip side, liver cancer registered 23.8% share in the overall market. According to WHO, in 2012, liver cancer became the primary reason of death for 745000 individual worldwide. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18656 On the basis of end user, the global tumor ablation market can be split into cancer specialty clinics, hospitals, and others. Hospitals is known to record the highest number of footfalls owing to rising practices of visiting hospitals for well-being, coupled with presence of advanced facilities in hospitals. On the other hand, cancer specialty clinics is expected to beat hospitals on the base of growth rate due to rising preference towards cancer specialty clinics. On the basis of geography, the market is segregated into Asia Pacific, Middle East and Africa, Latin America, Europe, and North America. Contribution by the U.S made North America to hold a staggering 34% of share in the overall market in recent years. Advanced healthcare facilities along with substantial awareness regarding the upcoming technologies for cancer has helped the market to grow in the region. However, in coming years, Asia Pacific due to rapid urbanization, expansion of healthcare facilities, accompanied with rising disposable income is likely to provide better opportunities to the players in the market. Some of the major players in the market are BVM Medical Limited, Sonacare Medical LLC, BTG Internation LET., and Medtronic plc. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18656 About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/  ^pop (Added: Mon Jan 28 2019 Hits: 112 Rating: 0.00 Votes: 0) Rate It

• Clinical Decision Support System Market to Witness CAGR of Over 11% from 2017 to 2025 - The global clinical decision support system market is rising with rule based expert system, funding from societies for improving point of care, and increasing primary healthcare support across the globe is expected to drive the growth of market. The global clinical decision support system market was valued over US$ 523.8 Mn in 2016 and is projected to witness cumulative annual growth rate (CAGR) of over 11% from 2017 to 2025 to surpass the value of US$ 1,318.4 Mn by 2025. The global market is witnessing relatively higher growth owing to increasing digitization of medical practices, high healthcare IT budgets and rise in demand for chair time optimization in developed markets. Read Report Overview: https://www.transparencymarketresearch.com/clinical-decision-support-system-market.html Clinical decision support system is an administrative as well as clinical tool that helps in improving operational efficiency of healthcare practices. The hospitals and clinics are required to handle with the large volume of patient information both administrative as well as clinical information. In order to handle the large volume of data, medical professionals and front office staff are always in search of effective way to record, store and improve the access to patient information in efficient manner. The clinical decision support system aids the medical professionals and patients to streamline the workflows of medical practices and thus to improve overall operational efficiency as well as patient care. Physician recommendation for updating systems with alert systems and new technological innovation by different key players can also accelerate the growth in clinical decision support system market. These factors collectively projected to drive the demand for global clinical decision support system in near future. Also, the technological advancements such as software integration facilities with other electronic health records is estimated to fuel the expansion of clinical decision support system market. The global clinical decision support system market is broadly segmented into four categories based on usage based, by application, by mode of advice, by delivery model, by end-user and by region. In terms of delivery model, the global market is categorized into on premise, web based and cloud based clinical decision support system. The market for on premise clinical decision support system accounted for key share (in terms of revenue) in global market in 2016, the cloud based clinical decision support system is estimated to grow at exponential growth rate during the forecast period and the segment is estimated to report significant gain in its market share by the end of 2025. The cloud based clinical decision support system offers the several advantages over on premise and web based clinical decision support system and thus, cloud based clinical decision support system is increasingly gaining popularity among physicians, especially among group dental practice management offices and clinics. By mode of advice, the global clinical decision support system market has been segmented into active clinical decision support system and passive clinical decision support system. Passive CDSS segment is anticipated to be the most attractive market due to advantages such as providing valid and reliable information, saving user’s time, integrating system recommendation alerts. However, increased voluntary disclosures and reducing intensity of lenders by the users are anticipated to boost the active CDSS segment from 2017 to 2025. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4332 In terms of application, the global clinical decision support system is segmented into drug databases, care plans, diagnostic decision support, disease reference, others. The drug database and diagnostic decision segment is dominated the global market and is likely to maintain its dominance by the end of 2025 with marginal increase in its market share. Increasing adoption of digital platforms by the younger population for appointment scheduling, creating alert system by physicians & nurses, value added features provided by the patient management and billing applications such as paperless patient data recording and storage, e-billing and insurance claiming etc. has led to prominent share of the segment in global market. Based on usage based, the clinical decision support system market is segmented as knowledge-based systems, expert laboratory information system, and machine learning systems. The knowledge-based systems segment dominated the global clinical decision support system market accounting for the highest share in 2016 as these usage based systems are mostly utilized due to rising incidences of various diseases resulting from medication errors. The knowledge-based systems segment is also expected to register the fastest growth rate during the forecast period due to growing need of integrate healthcare IT solutions in hospitals, clinics and others. Also, improved quality of care and clinical outcomes, and some favorable government initiatives is expected to propel the knowledge-based systems segment growth rate during forecast period. By end-user, the global market has been segmented into dental clinics and hospitals. Geographically, the global clinical decision support system market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the global market and is projected to lose its market share by the end of 2025. North America dominated the global clinical decision support system market in 2016 due to factors such as technologically advanced research and treatment platforms for diagnosis of chronic diseases, presence of a large number of reimbursement policies, rise in Canadian healthcare infrastructure, and increase in development of IT healthcare organizations in North America. Moreover, increase in the group medical practices has been observed in the United States which projected to fuel the expansion of cloud based clinical decision support system in the United States during the forecast period. Asia Pacific region is projected to be fastest growing region in global clinical decision support system market during the forecast period. In Asia Pacific region, China dominated the clinical decision support system market whereas India is estimated to grow at exponential CAGR during the forecast period. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4332 The companies like Allscripts Healthcare Solutions, Inc., First Databank, Inc., Truven Health Analytics, Cerner, Philips Healthcare, Siemens Healthcare etc. accounted for the major share in global clinical decision support system market in 2016. The Allscripts Healthcare Solutions, Inc., company has the higher share due to increasing adoption of IT in healthcare sector which is expected to drive clinical decision support system market in the forecast period. Other global players operating in the market include Optum, Inc. (UnitedHealth Group), GE Healthcare, and Epic Systems Corporation Inc. Companies are adopting the strategy acquisition and collaboration with parallel companies to improve and strengthen its geographic presence in international market. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Jan 28 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Specialized Medical Team by Global Air Ambulance from Silchar - January 28, 2019 - Global Air Ambulance Service has well-furnished Aircraft and very much safe and comfortable and is available at a very low budget that everyone can easily afford. It has all the newest equipment like Cardiac Monitor, Suction Machine, Infusion Pump, Oxygen Cylinders, Pacemakers, Defibrillator, and all the other required instruments. Global Air Ambulance provides the best service with all the healthcare products which include a hi-tech ventilator, cardiac monitor etc. This air ambulance provides full-time service and is always ready to do everything for the sake of the patient. Global has highly Dedicated and Responsible Medical Team Unit in Air Ambulance Services which are always to provide one of the best services all over the country. Why Global Air Ambulance All Flight/ Travel arrangement A thorough physical assessment of the patient to ensure their physical condition that qualifies them to fly/travel safely. Pre-trip medical intake physical assessment of the patient. Coordination between sending and receiving facilities to ensure transition in care. All medical care during the travel. Global Air Ambulance Service from Silchar is standing with its full-time basis and advance medical Facility such as- world-class highly experienced MD doctors, long time working flight expertise paramedics and nurses and medical staffs. It provides complete advanced medical facility with full hi-tech healthcare equipment in our both charter and commercial air ambulance in Silchar with all healthcare experts and qualified medical assistance. Global Air Ambulance Service in Siliguri almost cares for their requirements by providing them the most economical and affordable cost to get their patients survived within a span of short time duration. It provides a safe and secure bed to bed patient transfer facility at a very affordable and economical cost and one of the secure and fastest air ambulance services in Siliguri. More@ https://www.globalairambulance.in/air-ambulance-services-in-siliguri/ (Added: Mon Jan 28 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Lipid Disorder Treatment Market - Rising Demand for Modern Lipid Metabolism to Drive the Demand - Emergence of various lifestyle diseases has been witnessed worldwide, especially among teens and people lying in the 50-60 years age group. Lipid disorders are largely caused due to high cholesterol and triglycerides, which ultimately can result in increased chances of heart diseases, which has prompted the development of safe and efficient treatments for lipid disorders. Moreover, smoking and drinking have largely contributed to the rising prevalence of lipid disorders and other cardiovascular diseases among men and women. This has fuelled demand for advanced treatments such as introduction of modern lipid lowering drugs. The demand for lipid disorder treatments has risen owing to occupational diseases caused by higher consumption of alcohol results in rising amount of bad cholesterol or LDL, irregular eating habits, lack of body exercises and improper medication. Read Report Overview: https://www.transparencymarketresearch.com/lipid-disorder-treatment-market.html Analysis of Transparency Market Research shows that the global market for lipid disorder treatment is expected to grow at an exceptional pace during the period of assessment. This growth is fuelled by rising demand for modern lipid metabolism disorder treatments coupled with increased chances of cardiovascular diseases across the globe. The global market for lipid disorder treatment is poised to register a value CAGR of 7.4% during the period of assessment, 2017-2026. Several biopharma companies are focusing on developing effective solutions for treating lipid disorders. Companies involved in lipid disorder treatment market include Teva Pharmaceuticals, Mylan Pharmaceuticals, Inc., Kowa Pharmaceuticals America, Inc., Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals Industries Ltd., and Wockhardt Limited. United States has registered a higher number of people acquiring lipid disorders, especially among adults. Growing consumption of drugs such as atorvastatin and fluvastatin to treat hypercholesterolemia and other associated lipid disorders has been witnessed in the country. Several tests have been performed to identify patients who have a high risk of developing lipid disorders owing to family history or genetic disorders. According to American Academy of Pediatrics and National Heart, Lung and Blood Institute, atherosclerotic cardiovascular disease is a leading cause of death in the region. This has pushed the use of prescription drugs in the region, making it imperative for pharma companies to increase their production rate and revise their production cycles. In addition, screening for lipid disorders in childhood has been initiated in the region, and as per study, a moderate percentage of children population in the United States is being affected by lipid disorders, that typically surface as the child reaches its teenage. This has presented potential opportunities for sale of drugs for the treatment of lipid disorders in North America, making it an attractive region from a business point of view. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40640 As the risk of developing lipid disorders increases, pharmaceutical companies have initiated drug enhancement, introduction of new drugs and conducting phase trials of these drugs on a large scale. Statins are considered to be highly effective in lowering the rate cardiovascular events. Most companies are focusing on mass production of atorvastatin as they are a highly effective low density lipoprotein lowering agents, LDL being the main cause of lipid disorders and associated heart diseases. The consumption of atorvastatin is expected to grow at a higher rate. Market for atorvastatin is poised to reach a value of over US$ 16 Bn by the end of the assessment period. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Jan 28 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• World Allergy Immunotherapy Market Top Key Players Shares, Revenue, Analysis and Forecasts to 2023 - Market Research Future (MRFR)’s latest report reveals that the Global Allergy Immunotherapy Market is set to exhibit a steep rise in growth registering a CAGR of 10.85% during the forecast period 2017 to 2023. The market has been estimated to reach a valuation of USD 4,324.7 Mn by the end of 2023. The widespread prevalence of allergies has fueled demand in the allergy immunotherapy market. The trend is anticipated to perpetuate over the next couple of years. According to a report published by the World Health Organization (WHO), approximately 10-40% of the population was suffering from allergy in 2013. The increasing patient pool coupled with the availability of advanced allergy treatment procedures has augured well for the players of the allergy immunotherapy market. The market is expected to remain highly lucrative in the foreseeable future, and the increased investments in clinical trials and research & development activities are set to catapult the market on an upward trajectory. The developing healthcare sector in emerging markets in Latin America, Asia, etc. are anticipated to steer the growth of the allergy immunotherapy market. Other favorable factors encouraging the growth of the market include increasing awareness of the treatment, technological advancement, growth strategies of major players, etc. To Get Sample Report visit https://www.marketresearchfuture.com/sample_request/1517 Key Players for Global Allergy Immunotherapy Market Market Research Future (MRFR) recognizes the following companies as the key players in Allergy Immunotherapy Market: There are plenty of large and small market players which operate in this market all over the globe. Some of the key players profiled in the report are ALK Abello A/S (Denmark), DBV Technologies (France), Stallergenes Greer (UK), HAL Allergy Group (Netherlands), Allergy Therapeutics (UK), Merck KGaA (Allergopharma) (Germany), and Circassia (UK) among others. Industry Developments: In August 2018, Arrayit Corporation, life sciences, and personalized medicine company announced its partnership with multiple providers of allergen immunotherapy products for allergy testing to treat patients with allergy and asthma. In August 2018, Astria Sunnyside Hospital announced the availability of an allergy testing and treatment program. Allergy treatment options being offered at the hospital include sublingual immunotherapy and regular allergy shots. Segments for Global Allergy Immunotherapy Market By allergy type, the global allergy immunotherapy market has been segmented into allergic rhinitis, allergic asthma, peanut allergy, cat allergy, and other allergies. The allergic rhinitis segment currently accounts for a dominant share of the market. Meanwhile, the peanut allergy segment is estimated to register a CAGR of 11.3%. By treatment, the allergy immunotherapy market is segmented into Subcutaneous Immunotherapy (SCIT), sublingual immunotherapy, and Specific Immunotherapy (SIT). The Subcutaneous Immunotherapy (SCIT) segment holds the largest share of the market and is projected to reach a valuation of USD 2,089.2 by 2023. Regional Analysis for Global Allergy Immunotherapy Market By region, the global allergy immunotherapy market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Europe accounts for the maximum share of the market and is expected to retain a significant share of the market towards the end of the assessment period. Led by Western Europe, the factors favoring the growth of the regional market are increasing patient pool, rising healthcare expenditure, etc. Americas market is estimated to reach a valuation of USD 1,409.6 Mn by 2023. The growth is attributable to the increasing awareness regarding treatment of allergies and high prevalence of allergic rhinitis & skin allergy. Asia Pacific is projected to register a CAGR of 11.32% during the forecast period. Meanwhile, the U.A.E. currently holds 53.5% share of the Middle East & Africa market and resonates strong opportunities for growth. Browse Complete Report @ https://www.marketresearchfuture.com/reports/allergy-immunotherapy-market-1517 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com (Added: Mon Jan 28 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

Pages: [<<] ... 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 ... [>>]